News

Filter

Current filters:

Glumetza

1 to 9 of 44 results

PDL BioPharma secures royalties on diabetes products in $240m deal

PDL BioPharma secures royalties on diabetes products in $240m deal

22-10-2013

PDL BioPharma has acquired the rights to receive royalties and milestones payable on sales of Type 2…

DepomedDiabetesFinancialGlumetzaInvokanaJanumetLicensingmetforminNorth AmericaPDL BioPharmaPharmaceutical

Santarus and Depomed expand US deal on Glumetza

23-08-2011

US drugmakers Santarus (Nasdaq: SNTS) and Depomed (Nasdaq: DEPO) have entered into a new commercialization…

DepomedDiabetesGlumetzaLicensingNorth AmericaPharmaceuticalSantarus

Merck KGaA's Glucophage Powder cleared in UK and France

20-05-2009

Merck Serono, the pharmaceutical unit of Germany's Merck KGaA, says that Glucophage powder for oral solution…

FortametGlucophageGlucophage XRGlumetzaMerck KGaAMetformin HclNystatinOralRiomet

Merck & Co signs performance-based contract with CIGNA

24-04-2009

US health insurer CIGNA has reached an agreement with drug major Merck & Co that it says is unique in...

FortametGlucophageGlucophage XRGlumetzaJanumetJanuviaMerck KGaAMetformin HclNystatinOralRiometsitagliptinSitagliptin Metformin HCL

1 to 9 of 44 results

COMPANY SPOTLIGHT

Menarini

Back to top